Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

2026 Sun Life Hong Kong International Dragon Boat Races Marks Dragon Boat Championship’s 50th Anniversary with the City’s Largest Day‑and‑night Hong Kong Dragon Boat Festival Across 13 Days This June

May 5, 2026

neurocare group AG announces MDMA approval of TMS Devices in Saudi Arabia

May 5, 2026

Gauth Expands Across Southeast Asia With Rollout of Live Tutor AI Learning Feature

May 5, 2026

Cytospire Therapeutics announces oversubscribed £61 million ($83m) Series A financing to advance pipeline of first-in-class pan-gamma delta T cell engagers into clinical trials for the treatment of cancer

May 5, 2026

Serious Allegations of Conflicts of Interest and Process Bias Emerge in Argyle Aquaculture Approval System

May 5, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Ethos Cannabis to Close on 4/20 to Give the Holiday Back to Its People and Patients
Press Release

Ethos Cannabis to Close on 4/20 to Give the Holiday Back to Its People and Patients

By News RoomApril 2, 20265 Mins Read
Ethos Cannabis to Close on 4/20 to Give the Holiday Back to Its People and Patients
Share
Facebook Twitter LinkedIn Pinterest Email

PHILADELPHIA, April 02, 2026 (GLOBE NEWSWIRE) — On April 20th, while cannabis retailers across the country are preparing for one of their highest-revenue days of the year, Ethos Cannabis will be closed. The decision to close every store in every market was announced to all employees at the company’s All-Hands meeting in December, giving every Ethos employee a paid day off to spend however they choose.

“4/20 started as something simple and personal with friends, flower, and time together,” said Gibran Washington, CEO of Ethos Cannabis. “Somewhere along the way, the day got louder. What began as a celebration of the plant is closer today to a retail frenzy, with discounts and doorbusters driving the conversation instead of intention and care. This year, we’re reclaiming 4/20 for what it was always meant to be, a genuine celebration of the plant, the people who love it, and the patients whose lives it changes.”

“If the loudest message on 4/20 is about the price of cannabis, we train people to see it as a commodity, a race to the bottom for operators, not a product that deserves care, education, and trust. We want to change the conversation and get back to the original spirit of 4/20, because the long-term health of this industry depends on it,” added Washington.

Giving the Day Back
The closure was announced internally in December and added to the company’s official employee holiday calendar for 2026.

“The people who work at Ethos show up 365 days a year to educate patients, answer hard questions, and stand up for their communities with genuine care. On one of the industry’s biggest sales days, they are usually the ones making it happen. This year, 4/20 belongs to them,” added Washington.

All retail locations across Pennsylvania, Massachusetts, and Ohio will be closed on April 20th. Wholesale operations will run on a normal cadence, with proactive communication to partners to ensure no disruption to ordering timelines.

“More Than a Day” Is a Month-Long Campaign
Closing on 4/20 is just one aspect of the “More Than a Day” campaign, which runs the entire month of April, and helps Ethos step further into the cannabis culture it is committed to fostering. Built around physician-led content, curated product discovery, and education that helps patients find what actually works for them, the campaign replaces a single transactional spike with a full month of meaningful engagement to help people build a healthier, more intentional relationship with cannabis.

April programming includes new strain review content, shoppable product collections, personalized patient recommendations, and a campaign-wide focus on education across all Ethos digital and in-store channels. Ethos is sharing the full April plan early so patients and customers can plan ahead, with clear options to shop before and after the 20th.

The Physician Difference
Central to the “More Than a Day” campaign is Dr. William McLay, Ethos’ lead pharmacist and medical expert. As a credentialed clinician working directly with patients every day, Dr. McLay brings a perspective to cannabis retail that the industry rarely sees at the point of purchase.

“What people actually need from cannabis rarely starts with a discount,” said Dr. McLay. “It starts with someone who will actually listen. I work directly with patients every day, and what I hear consistently is that they want guidance they can trust over a sale that creates urgency. That’s what the ‘More Than a Day’ campaign is built around.”

Throughout April, Dr. McLay’s clinical insights will be embedded directly into Ethos’ strain descriptions, video content, and patient-facing educational resources.

What Comes Next
Ethos believes the industry deserves a different kind of 4/20 story. In that spirit, the company is committing to transparency about how April performs, with the hope that other operators might consider reshaping their own approach to the holiday.

“We’re approaching this with the intention of building something repeatable,” Washington said. “We’ll evaluate the results honestly and share what we learn, including if it doesn’t work the way we hope.”

The “More Than a Day” campaign runs April 1 through April 30, 2026. Patients can find full details on programming, product availability, and educational content at ethoscannabis.com.

About Ethos Cannabis
Ethos Cannabis is a multi-state operator with operations in Pennsylvania, Massachusetts, and Ohio. Ethos also boasts four brands in its portfolio, Natural Selections (MA & PA), Eleven (MA & PA), Headliners (MA), and Meigs County (OH). Ethos is a leading vertically integrated, retail-focused platform in the Mid-Atlantic, East Coast, and Midwest markets of the U.S. This platform serves mainstream consumers while expanding the health and wellness market through relationships with Thomas Jefferson University and other academic medical institutions and strategic partnerships. Ethos is dedicated to helping individuals feel and live better through their experiences with cannabis. For more information on Ethos, visit ethoscannabis.com.

Media Contact:
Erin Roche
[email protected]
347.702.2137

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/6d1c92e2-907c-4752-82b1-c11d128bf55d

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

2026 Sun Life Hong Kong International Dragon Boat Races Marks Dragon Boat Championship’s 50th Anniversary with the City’s Largest Day‑and‑night Hong Kong Dragon Boat Festival Across 13 Days This June

neurocare group AG announces MDMA approval of TMS Devices in Saudi Arabia

Gauth Expands Across Southeast Asia With Rollout of Live Tutor AI Learning Feature

Cytospire Therapeutics announces oversubscribed £61 million ($83m) Series A financing to advance pipeline of first-in-class pan-gamma delta T cell engagers into clinical trials for the treatment of cancer

Serious Allegations of Conflicts of Interest and Process Bias Emerge in Argyle Aquaculture Approval System

Kalmar secures first customised training simulator order from SSAB Oxelösund

YNG Group Attends Overseas Investment Fair 2026 in Shanghai

AUO Leads a New Micro LED Interaction Paradigm at SID 2026

Gauth Launches Live Tutor in Vietnam, Expanding Access to Personalized AI Learning Support

Editors Picks

neurocare group AG announces MDMA approval of TMS Devices in Saudi Arabia

May 5, 2026

Gauth Expands Across Southeast Asia With Rollout of Live Tutor AI Learning Feature

May 5, 2026

Cytospire Therapeutics announces oversubscribed £61 million ($83m) Series A financing to advance pipeline of first-in-class pan-gamma delta T cell engagers into clinical trials for the treatment of cancer

May 5, 2026

Serious Allegations of Conflicts of Interest and Process Bias Emerge in Argyle Aquaculture Approval System

May 5, 2026

Latest News

Kalmar secures first customised training simulator order from SSAB Oxelösund

May 5, 2026

Fires, floods highlighted during Emergency Preparedness Week

May 5, 2026

Calgarians more trusting of city hall, less satisfied with city services: survey

May 5, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version